Tumor Course Faculty – 2024
Course Director
Rakesh K. Jain, Ph.D., Andrew Werk Cook Professor of Radiation Oncology (Tumor Biology), Harvard Medical School; Director, E.L. Steele Laboratories of Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA
Faculty
- George Coukos, M.D., Ph.D., Professor; Director of Hi-TIDe - Human integrated tumor immunology discovery engine; Head of the Department of oncology; Department of oncology UNIL CHUV, Ludwig Institute for Cancer Research, Lausanne, Switzerland
- Lisa M. Coussens, Ph.D., Hildegard Lamfrom Chair in Basic Science; Professor and Chair, Cell and Developmental Biology; Associate Director for Basic Research, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA
- Issam El Naqa, Ph.D., DABR, FAAPM, FIEEE, FAIMBE, Chair and Senior Member, Distinguished Moffitt Scholar, Moffitt Cancer Center, Tampa, FL, USA
- Gordon J. Freeman, PhD, Professor, Department of Medical Oncology, Dana-Farber Cancer Institute and Professor of Medicine, Harvard Medical School, Boston, MA, USA
- Rakesh K. Jain, Ph.D., Andrew Werk Cook Professor of Tumor Biology, Harvard Medical School; Director, E.L. Steele Laboratories of Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA
- Carl H. June, M.D., Richard W. Vague Professor in Immunotherapy, Department of Pathology and Laboratory Medicine; Director of the Center for Cellular Immunotherapies; Director of the Parker Institute for Cancer Immunotherapy; University of Pennsylvania, Philadelphia, PA, USA
- Michelle Monje, M.D., Milan Gambhir Professor of Pediatric Neuro-oncology; Professor, by courtesy, of Neurosurgery, of Pediatrics, of Pathology and of Psychiatry and Behavioral Sciences, Stanford Medicine, Stanford, CA, USA
- Mario L. Suva, M.D., Ph.D., Associate Professor of Pathology, Massachusetts General Hospital and Harvard Medical School Associate Member at the Broad Institute of MIT and Harvard, Co-Director, Cancer Program, Harvard Stem Cell Institute, Boston, MA, USA
-
Michael D. Taylor, M.D., Ph.D., F.R.C.S., Director, Neuro-oncology Research Program
Professor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston, TX, USA - David A. Tuveson, M.D., Ph.D., Professor and Director, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA
- Chi Van Dang, M.D., Ph.D., Scientific director, Ludwig Institute for Cancer Research; Bloomberg Distinguished Professor of Cancer Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Matthew Vander Heiden, M.D., Ph.D., Associate Professor of Biology, Massachusetts Institute of Technology; Associate Director, Koch Institute for Integrative Cancer Research, Cambridge, MA, USA
- Jennifer A. Wargo, M.D., Professor, Surgical Oncology & Genomic Medicine; Program Director for PRIME TR, MD Anderson Cancer Center, Houston, TX, USA
- Robert A. Weinberg, Ph.D., Daniel K. Ludwig Professor for Cancer Research at Massachusetts Institute of Technology, Director of the Ludwig Center of the MIT, and American Cancer Society Research Professor